Institute for the Application of Nuclear Energy, INEP, University of Belgrade, 11080 Belgrade, Serbia.
Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, 0379 Oslo, Norway.
Int J Mol Sci. 2021 Apr 9;22(8):3887. doi: 10.3390/ijms22083887.
Renal fibrosis is a complex disorder characterized by the destruction of kidney parenchyma. There is currently no cure for this devastating condition. Extracellular vesicles (EVs) are membranous vesicles released from cells in both physiological and diseased states. Given their fundamental role in transferring biomolecules to recipient cells and their ability to cross biological barriers, EVs have been widely investigated as potential cell-free therapeutic agents. In this review, we provide an overview of EVs, focusing on their functional role in renal fibrosis and signaling messengers responsible for EV-mediated crosstalk between various renal compartments. We explore recent findings regarding the renoprotective effect of EVs and their use as therapeutic agents in renal fibrosis. We also highlight advantages and future perspectives of the therapeutic applications of EVs in renal diseases.
肾纤维化是一种复杂的疾病,其特征是肾脏实质的破坏。目前,这种破坏性疾病还没有治愈方法。细胞外囊泡(EVs)是在生理和病理状态下从细胞中释放的膜性囊泡。鉴于它们在将生物分子传递给受体细胞方面的基本作用及其穿过生物屏障的能力,EVs 已被广泛研究作为潜在的无细胞治疗剂。在这篇综述中,我们提供了 EVs 的概述,重点介绍了它们在肾纤维化中的功能作用以及负责 EV 介导的各种肾脏隔室之间串扰的信号信使。我们探讨了关于 EVs 的肾保护作用及其在肾纤维化中作为治疗剂的最新发现。我们还强调了 EVs 在肾脏疾病治疗应用中的优势和未来展望。